Presentation: The Agency Viewpoint on Social Media and Pharma
Presented by: Bruce Grant, SVP, Business Strategy, Digitas Health & Presenter at the FDA Hearings
There's a big conversation going on in social media that is, for most consumers, more influential than mass marketing or any mass medium, and nowhere is this more relevant than in health. Yet pharma has, to date, been a distant and peripheral presence in these crucial conversations. What do pharma marketers need to know to be able to listen to, learn from, and engage with these conversations without getting fired, sued, or indicted? Industry veteran Bruce Grant will share thoughts on this and the FDA hearings from the pharmaceutical marketer's point of view.
Presentation: Parting the Gray Sea: Finding a Path for Social Media After the Divine Hearing
Presented by: Shwen Gwee, Corporate Communications, Vertex Pharmaceuticals & Founder, Social Pharmer Network
Presentation: The World is Filled with Critics
Presented by: Ray Kerins, Vice President, Worldwide Communications & Head, Global Corporate Media Relations, Pfizer, Inc.
Presentation: Social Media Regulation Fear and Loathing in Washington, DC: What's Next is What Counts
Presented by: John Mack, Editor and Publisher, Pharma Marketing News / Pharma Marketing Blog & Presenter at the FDA Hearings
Presentation: Beyond Anecdotes and Cases
Presented by: Mario R. Nacinovich Jr., Editor-in-Chief, Journal of Communication in Healthcare How we can Benchmark and Determine Best Practices in Healthcare Social Media with or without the FDA.
Presentation: Three Things I Learned from the FDA Social Media Hearings, and Three Things I Wish I Did
Presented by: Jonathan Richman, Director of Strategic Planning, Bridge Worldwide & Author, Dose of Digital & Presenter at the FDA Hearings
